RevMed, Merck, Moderna, Auchincloss: Readout Newsletter

by AiNewsBlog Oct, 18

written by AiNewsBlog Oct, 18 0 comments

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

We’re leaving room for popcorn and intrigue tonight: The new A24 documentary, “You Can See Everything,” hits theaters today.

I remember back at the American Association for Clinical Chemistry meeting in 2016, a skeptical pathologist told me in advance of a purported Theranos data unveil:

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

AiNewsBlog

Anthropic’s AI Safety Bill Has an Alarming Threshold for Government Action – Mother Jones

Leave a Comment Cancel Reply

Name	Price	7d %	Volume
Bitcoin btc	$81,872	-1.44%	$15,832,823,701
Ethereum eth	$2,413	-3.54%	$6,771,071,248
XRP xrp	$1.29	-7.02%	$978,835,856
Solana sol	$104	-5.08%	$1,968,141,854
Dogecoin doge	$0.079	-7.01%	$411,621,736

At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.